VENUSS prognostic score for non-metastatic papillary renal cell carcinoma
This is a prediction model for disease recurrence following partial or radical nephrectomy for non-metastatic papillary renal cell carcinoma (T1-T4 N0-1 M0). The model is based on routine pathology and includes the variables T classification, N classification, tumour size, grade and presence of venous tumour thrombus. Based on the continuous VENUSS score, there are three groups with regard to the risk of recurrence: low risk (0–2 points), intermediate risk (3 to 5 points) and high risk (6 points or greater). VENUSS is an acronym for VEnous tumour thrombus, NUclear grade, Size, and Stage.  
Research authors: Tobias Klatte, Kevin M. Gallagher, Luca Afferi, Alessandro Volpe, Nils Kroeger, Silvia Ribback, Alan McNeill, Antony C. P. Riddick, James N. Armitage, Tevita F. 'Aho, Tim Eisen, Kate Fife, Axel Bex, Allan J. Pantuck, Grant D. Stewart
Details Formula Study characteristics Files & References
Model author
Model ID
Revision date
MeSH terms
  • Kidney Cancer
  • Prognosis
  • Disease Free Survival
  • Recurrence
  • Papillary Renal Cell Carcinoma
  • Nephrectomy
  • Model type
    Custom model (Calculation)

    Additional information

    No additional information available

    Study Population

    Total population size: 556

    Additional characteristics

    No additional characteristics defined
    VENUSS prognostic score for non-metastatic papillary renal cell carcinoma
    Refer to Intended Use for instructions before use
    Evidencio B.V., Irenesingel 19, 7481 GJ, Haaksbergen, the Netherlands

    The VENUSS score is

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Notes are only visible in the result download and will not be saved by Evidencio

    The VENUSS score is

    {{ resultSubheader }}
    {{ chart.title }}

    Outcome stratification

    Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

    Conditional information

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:

    Please sign in to enable Evidencio print features

    In order to use the Evidencio print features, you need to be logged in.
    If you don't have an Evidencio Community Account you can create your free personal account at:

    Printed results - Examples {{ new Date().toLocaleString() }}

    Evidencio Community Account Benefits

    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.